WeVote
Log In

Bill

Bill

SB 1473

AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

2025 Regular Session Introduced by Saud Anwar and 9 co-sponsors

Connecticut requires Medicaid coverage of FDA-approved gene therapies for sickle cell disease, removing prior authorization requirements to expand patient access to potentially curative treatments.

SIGNED BY GOVERNOR
#medicaid #reports #sicklecelldisease #socialservices #departmentof
0
WeVote Research Nonpartisan
Bill Summary · SB 1473

Legislative bill overview

SB 1473 mandates that Connecticut's Medicaid program cover FDA-approved gene therapies for treating sickle cell disease without prior authorization delays or coverage denials. The bill became law in June 2025 after passing both chambers and receiving gubernatorial approval. It removes barriers that might prevent eligible patients from accessing these cutting-edge treatments.

Why is this important

Sickle cell disease disproportionately affects Black and Hispanic populations in Connecticut and causes severe pain, organ damage, and shortened lifespans. Gene therapies represent potentially curative treatments, but their high costs ($2+ million per treatment) make insurance coverage decisions critical to patient access. This law ensures Medicaid beneficiaries can obtain these therapies without insurance bureaucracy blocking treatment.

Potential points of contention

  • Cost to state budget: Gene therapies are extraordinarily expensive; covering multiple patients could significantly strain Connecticut's Medicaid budget, potentially requiring reallocation from other health programs
  • Prior authorization removal: Eliminating medical review processes means clinicians decide treatment without independent verification that patients meet clinical criteria, raising appropriateness concerns
  • Definition ambiguity: The bill's scope regarding which "FDA-approved" therapies qualify and under what clinical conditions may create disputes between insurers and patients about coverage eligibility

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.